Relationship Between Timing of PCSK9 Inhibitor Monoclonal Antibody Initiation and Clinical Outcomes in Patients with Prior Cardiovascular Events

Sidelnikov E, Kalich BA, Miglins ML, Multani JK, Tuly R, Hawkins K, Baber U

Therapeutics and Clinical Risk Management 2025, 21:727-736

Published Date: 21 May 2025